embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference
Embecta Corp. (NASDAQ: EMBC) has announced its participation in the upcoming J.P. Morgan Healthcare Conference on January 11, 2023, at 9:45 a.m. PT / 12:45 p.m. ET. The company, known for its significant role in diabetes care, previously operated under Becton, Dickinson and Company. Interested parties can access audio webcasts of the presentation through the Company’s investor relations website. With nearly 100 years in insulin delivery, Embecta aims to enhance the lives of individuals with diabetes through innovative solutions and a dedicated workforce of over 2,000 employees worldwide.
- None.
- None.
PARSIPPANY, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 11, 2023 at 9:45 a.m. PT / 12:45 p.m. ET.
Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.
About embecta
embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com.
CONTACTS
Investors:
Pravesh Khandelwal
VP, Head of Investor Relations
551-264-6547
Contact IR
Media:
Christian Glazar
Sr. Director, Corporate Communications
908-821-6922
Contact Media Relations
FAQ
When will Embecta Corp. present at the J.P. Morgan Healthcare Conference?
How can I access the audio webcasts of Embecta's presentation?
What is Embecta Corp.'s focus in the diabetes care market?
What is the stock symbol for Embecta Corp.?
What significant change did Embecta Corp. undergo recently?
